Relationship between biomarkers and findings on low-dose computed tomography in hospitalised patients with acute exacerbation of COPD

Hendrik J. Prins, Ruud Duijkers, Gerdien Kramer, Els Boerhout, Floris J. Rietema, Pim A. de Jong, Marianne Schoorl, Tjip S. van der Werf, Wim G. Boersma*

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

4 Downloads (Pure)


Background Acute exacerbations of COPD (AECOPD) and community acquired pneumonia (CAP) often coexist. Although chest radiographs may differentiate between these diagnoses, chest radiography is known to underestimate the incidence of CAP in AECOPD. In this exploratory study, we prospectively investigated the incidence of infiltrative changes using low-dose computed tomography (LDCT). Additionally, we investigated whether clinical biomarkers of CAP differed between patients with and without infiltrative changes.

Methods Patients with AECOPD in which pneumonia was excluded using chest radiography underwent additional LDCT-thorax. The images were read independently by two radiologists; a third radiologist was consulted as adjudicator. C-reactive protein (CRP), procalcitonin (PCT), and serum amyloid A (SAA) at admission were assessed.

Results Out of the 100 patients included, 24 had one or more radiographic abnormalities suggestive of pneumonia. The interobserver agreement between two readers (Cohen's kappa) was 0.562 (95% CI 0.371-0.752; p

Conclusion LDCT can detect additional radiological abnormalities that may indicate acute-phase lung involvement in patients with AECOPD without infiltrate(s) on the chest radiograph. Despite CRP, PCT and SAA being significantly higher in the group with radiological abnormalities on LDCT, they proved unable to reliably detect or exclude CAP. Further research is warranted.

Originele taal-2English
Aantal pagina's8
TijdschriftERJ Open Research
Nummer van het tijdschrift2
StatusPublished - 6-apr-2022

Citeer dit